Giorgia Guglielmi

Gut microbiota might predict risk of liver diseases

Researchers found that models of conventional risk factors and data on the gut microbiota improved the prediction of liver diseases

Bacteria in tumors may help cancer to metastasize

New research indicates that the tumor-resident microbiota can promote the formation of metastases as well as the survival of cancer cells during tumor progression.

Gut microbiota composition varies extensively within people

By analyzing stool samples from dozens of people in Sweden, researchers have found that the microbiota isn’t stable in adulthood.

Gut bacteria may influence the levels of cardiometabolic risk marker

Researchers have identified 10 species whose abundance was linked to blood levels of TMAO, a metabolite associated with cardiovascular diseases

Microbial cooperation helps fungal pathogens to tolerate drugs

Researchers have found that cooperation among microbial cells may be one of causes of this drug tolerance.

Lifestyle changes may boost the success of microbial transplants in people with diabetes

Repeated fecal microbiota transplants can improve the gut colonization of beneficial microbes in people with obesity and type 2 diabetes.

The microbiota may contribute to chronic liver disease by activating immune cells

To elucidate the role of the microbiota in PSC, researchers studied a type of immune cells called mucosal-associated invariant T (MAIT) cells, which are abundant in the liver.

Gut microbes may help frogs handle heat

Researchers have found that gut microbes can help frogs to cope with hot temperatures. The findings could pave the way to for new conservation approaches for animals threatened by climate…

Gut microbes may contribute to damage the aging brain’s immune cells

The impact of age-induced microbiota alterations facilitates the accumulation of CML metabolite in the microglia of mice and humans.

Microbial metabolite may boost antitumor immunity in aggressive breast cancer

Researchers have found that a specific microbial metabolite may boost the efficacy of anticancer therapy in people with TNBC. The findings could inform the development of improved treatments for TNBC.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top